FDA commissioner watch
This article was originally published in The Gray Sheet
Massachusetts will be the first state to welcome the not-yet-nominated candidate to head the agency, Sen. Ted Kennedy (D-Mass.) predicts May 11 at the MassMEDIC conference in Waltham, Massachusetts. "I'm looking forward to the time when we finally have our new commissioner of the FDA, and we know that the first stop of that commissioner is going to be in Massachusetts," he says. Kennedy anticipates a close working relationship between the new commissioner and members of the Massachusetts medical device industry council, "the kind of partnership we were beginning to develop - and which I thought made some impressive progress - with our last" commissioner. Jane Henney, VP-Health Sciences at the University of New Mexico, is understood to have been notified the week of March 2 by President Clinton of her selection for the post, although she has yet to be officially nominated pending an FBI background check ("The Gray Sheet" March 16, p. 8). Kennedy encouraged the Administration to select Henney over current Acting Commissioner Michael Friedman...
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.